Cardio-oncology: New challenge in clinical practice
There is a daily increase in the number of patients with malignant diseases, but with the advances in modern oncology research, the number of survivors treated with malignant diseases is becoming larger and larger. The survival rate after completing oncology therapy is increasing on a daily basis, so that malignant diseases belonging to the categor...
By Srđan Popović, Sladjana Popović, Nikolina Dukić, Olivera Čančar, Jelena Vladičić Mašić
Clinical characteristics, prognosis and outcome of patients with repaired tetralogy of Fallot
Progress in diagnosis and treatment has led to a significant improvement in the fate of children born with tetralogy of Fallot, with the perioperative mortality of 2-3% and a 30-year survival rate of 90%. However, the majority of these patients have residual postoperative morphological and hemodynamic disorders, as well as heart rhythm disorders, p...
By Biljana Milinković, Dejan Bokonjić, Verica Prodanović
Preoperative treatment of locally advanced gastrointenstinal cancer
Surgical treatment of locally advanced gastrointestinal cancer alone does not exhibit satisfactory local disease control and survival rate. The advantage of using radio and chemotherapy at this stage is to reduce the likelihood of developing local recurrence with an extension of survival time, while the disadvantages are the increase in postoperati...
By Ljiljana Vasić
Immunohistochemical markers: Carcinoembryonic antigen, p53, Ki-67, and proliferating cell nuclear antigen as prognostic factors for colorectal cancer
Introduction. There has been a progressive increase in the frequency of colorectal carcinoma for the last twenty years. In order for a doctor to estimate the life expectancy and/or the treatment of these patients, oncology makes use of prognostic and predictive factors. They are divided into: clinicosurgical, pathohistological and immunohistochemic...
By Siniša Maksimović, Branislava Jakovljević, Zdenka Gojković, Zlatko Maksimović